Summit Global Investments - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$1,187,000
-60.8%
18,582
-34.3%
0.09%
-55.4%
Q4 2021$3,031,000
+22.4%
28,294
+17.4%
0.20%
+4.8%
Q3 2021$2,477,00024,0920.19%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders